Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom.
The Leeds Department of Neurosciences, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
PLoS One. 2018 May 24;13(5):e0197969. doi: 10.1371/journal.pone.0197969. eCollection 2018.
The potential use of bone progenitors, multipotential stromal cells (MSCs) helping spine fusion is increasing, but convenient MSC sources and effective processing methods are critical factors yet to be optimised. The aim of this study was to test the effect of bone marrow processing on the MSC abundance and to compare the differentiation capabilities of vertebral body-bone marrow (VB-BM) MSCs versus iliac crest-bone marrow (IC-BM) MSCs. We assessed the effect of the red blood cell lysis (ammonium chloride, AC) and density-gradient centrifugation (Lymphoprep™, LMP), on the extracted VB-BM and IC-BM MSC numbers. The MSC abundance (indicated by colony counts and CD45lowCD271high cell numbers), phenotype, proliferation and tri-lineage differentiation of VB-BM MSCs were compared with donor-matched IC-BM MSCs. Importantly, the MSC attachment and osteogenesis were examined when VB-BM and IC-BM samples were loaded on a beta-tricalcium phosphate scaffold. In contrast to LMP, using AC yielded more colonies from IC-BM and VB-BM aspirates (p = 0.0019 & p = 0.0201 respectively). For IC-BM and VB-BM, the colony counts and CD45lowCD271high cell numbers were comparable (p = 0.5186, p = 0.2640 respectively). Furthermore, cultured VB-BM MSCs exhibited the same phenotype, proliferative and adipogenic potential, but a higher osteogenic and chondrogenic capabilities than IC-BM MSCs (p = 0.0010 and p = 0.0005 for calcium and glycosaminoglycan (GAG) levels, respectively). The gene expression data confirmed higher chondrogenesis for VB-BM MSCs than IC-BM MSCs, but osteogenic gene expression levels were comparable. When loaded on Vitoss™, both MSCs showed a similar degree of attachment and survival, but a better osteogenic ability was detected for VB-BM MSCs as measured by alkaline phosphatase activity (p = 0.0386). Collectively, the BM processing using AC had more MSC yield than using LMP. VB-BM MSCs have a comparable phenotype and proliferative capacity, but higher chondrogenesis and osteogenesis with or without using scaffold than donor-matched IC-BM MSCs. Given better accessibility, VB-BM could be an ideal MSC source for spinal bone fusion.
骨髓祖细胞,多能基质细胞(MSCs)在帮助脊柱融合方面的潜在用途正在增加,但方便的 MSC 来源和有效的处理方法是仍需优化的关键因素。本研究旨在测试骨髓处理对 MSC 丰度的影响,并比较椎体骨髓(VB-BM)MSCs 与髂嵴骨髓(IC-BM)MSCs 的分化能力。我们评估了红细胞裂解(氯化铵,AC)和密度梯度离心(Lymphoprep™,LMP)对提取的 VB-BM 和 IC-BM MSC 数量的影响。通过集落计数和 CD45lowCD271high 细胞数来比较 VB-BM MSC 的 MSC 丰度(表示为)、表型、增殖和三系分化与供体匹配的 IC-BM MSC。重要的是,当 VB-BM 和 IC-BM 样本加载到β-磷酸三钙支架上时,检查了 MSC 附着和成骨作用。与 LMP 相比,AC 从 IC-BM 和 VB-BM 抽吸物中产生了更多的集落(p = 0.0019 和 p = 0.0201)。对于 IC-BM 和 VB-BM,集落计数和 CD45lowCD271high 细胞数相当(p = 0.5186,p = 0.2640)。此外,培养的 VB-BM MSC 表现出相同的表型、增殖和脂肪形成潜力,但成骨和软骨形成能力高于 IC-BM MSC(钙和糖胺聚糖(GAG)水平分别为 p = 0.0010 和 p = 0.0005)。基因表达数据证实 VB-BM MSC 的软骨形成能力高于 IC-BM MSC,但成骨基因表达水平相当。当加载到 Vitoss™上时,两种 MSC 均表现出相似的附着和存活程度,但 VB-BM MSC 的碱性磷酸酶活性检测到更好的成骨能力(p = 0.0386)。总的来说,使用 AC 的 BM 处理比使用 LMP 产生更多的 MSC。VB-BM MSC 具有相似的表型和增殖能力,但具有更高的软骨形成和成骨能力,无论是否使用支架,与供体匹配的 IC-BM MSC 相比。鉴于更好的可及性,VB-BM 可能是脊柱骨融合的理想 MSC 来源。